Key facts
- Target
- Hepatitis A virus
- Vaccine type
- Inactivated or attenuated
- Trade names
- Havrix, others
- Ahfs drugs com
- Monograph
- Medlineplus
- a695003
- Pregnancy category
- Australia</span>"}]]}'>AU : B2
- Routes of administration
- Intramuscular
- Atc code
- J07BC02 ( WHO )
- Legal status
- Australia</span>"}]]}'>AU : S4 (Prescription only) United States</span>"}]]}'>US : ℞-only European Union</span>"}]]}'>EU : Rx-only In general: ℞ (Prescription only)
- Drugbank
- DB10989
- Chemspider
- none
- Unii
- G54MT8V18G
via Wikipedia infobox
Article
Hepatitis A vaccine is a vaccine that prevents hepatitis A. It is effective in around 95% of cases and lasts for at least twenty years and possibly a person's entire life. If given, two doses are recommended beginning after the age of one. It is given by injection into a muscle. The first hepatitis A vaccine was approved in the European Union in 1991, and the United States in 1995. It is on the World Health Organization's List of Essential Medicines.
The World Health Organization (WHO) recommends universal vaccination in areas where the disease is moderately common. Where the disease is very common, widespread vaccination is not recommended as people typically develop immunity through infection during childhood. The US Centers for Disease Control and Prevention (CDC) recommends vaccinating:
Gallery (2)
Connections
Categories
Chemical articles without CAS registry numberChemicals that do not have a ChemSpider ID assignedDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs developed by GSK plcDrugs developed by Merck & Co.Drugs that are a vaccineDrugs with non-standard legal statusHepatitis AHepatitis vaccinesInactivated vaccines